Tower Research Capital (TRC)’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.9K | Sell |
6,377
-1,955
| -23% | -$13.5K | ﹤0.01% | 3083 |
|
|
2025
Q1 | $24K | Buy |
8,332
+4,357
| +110% | +$12.5K | ﹤0.01% | 2799 |
|
|
2024
Q4 | $18.7K | Sell |
3,975
-24,145
| -86% | -$113K | ﹤0.01% | 3242 |
|
|
2024
Q3 | $100K | Buy |
28,120
+11,796
| +72% | +$42.1K | ﹤0.01% | 2229 |
|
|
2024
Q2 | $101K | Buy |
16,324
+6,473
| +66% | +$40.1K | ﹤0.01% | 2572 |
|
|
2024
Q1 | $93K | Buy |
9,851
+6,193
| +169% | +$58.5K | ﹤0.01% | 1866 |
|
|
2023
Q4 | $24.7K | Sell |
3,658
-1,589
| -30% | -$10.7K | ﹤0.01% | 3529 |
|
|
2023
Q3 | $23.3K | Sell |
5,247
-5,773
| -52% | -$25.6K | ﹤0.01% | 3236 |
|
|
2023
Q2 | $36.4K | Buy |
11,020
+5,100
| +86% | +$16.8K | ﹤0.01% | 2838 |
|
|
2023
Q1 | $17K | Buy |
5,920
+4,096
| +225% | +$11.8K | ﹤0.01% | 3629 |
|
|
2022
Q4 | $13K | Sell |
1,824
-289
| -14% | -$2.06K | ﹤0.01% | 3602 |
|
|
2022
Q3 | $17K | Sell |
2,113
-3,790
| -64% | -$30.5K | ﹤0.01% | 4063 |
|
|
2022
Q2 | $28K | Buy |
5,903
+5,239
| +789% | +$24.9K | ﹤0.01% | 3440 |
|
|
2022
Q1 | $16K | Sell |
664
-2,963
| -82% | -$71.4K | ﹤0.01% | 3751 |
|
|
2021
Q4 | $65K | Buy |
3,627
+3,093
| +579% | +$55.4K | ﹤0.01% | 2555 |
|
|
2021
Q3 | $15K | Sell |
534
-1,119
| -68% | -$31.4K | ﹤0.01% | 3972 |
|
|
2021
Q2 | $17K | Buy |
1,653
+633
| +62% | +$6.51K | ﹤0.01% | 4040 |
|
|
2021
Q1 | $12K | Sell |
1,020
-4,179
| -80% | -$49.2K | ﹤0.01% | 4259 |
|
|
2020
Q4 | $61K | Sell |
5,199
-8,356
| -62% | -$98K | ﹤0.01% | 2894 |
|
|
2020
Q3 | $107K | Buy |
13,555
+11,084
| +449% | +$87.5K | ﹤0.01% | 3105 |
|
|
2020
Q2 | $45K | Buy |
+2,471
| New | +$45K | ﹤0.01% | 3130 |
|
|
2019
Q4 | – | Sell |
-931
| Closed | -$6K | – | 3804 |
|
|
2019
Q3 | $6K | Buy |
+931
| New | +$6K | ﹤0.01% | 3214 |
|